Guo Qiuting, Wang Jinhui, Ni Caixia, Pan Jiaojiao, Zou Junbo, Shi Yajun, Sun Jing, Zhang Xiaofei, Wang Deng, Luan Fei
College of Pharmacy, Xianyang Polytechnic Institute, Xianyang, China.
Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an, Shaanxi, China.
Front Pharmacol. 2024 Aug 22;15:1445349. doi: 10.3389/fphar.2024.1445349. eCollection 2024.
Coronary heart disease is a prevalent cardiovascular ailment globally, with myocardial infarction (MI) being one of its most severe manifestations. The morbidity and mortality of MI are escalating, showing an increasing trend among younger, highly educated individuals, thereby posing a serious threat to public health. Currently, thrombolysis, percutaneous coronary intervention, and coronary artery bypass grafting are the primary clinical treatments for MI. Although these methods significantly reduce patient mortality, complications often result in poor prognoses. Due to limitations in chemical synthetic drug research, the focus has shifted towards developing herbs based on natural substances. Natural medicines represent a novel approach for safer and more effective MI management and treatment. They can control multiple pathogenic variables by targeting various pathways and systems. This paper investigates the molecular mechanisms of MI and evaluates the application of natural products and medicinal plants in MI treatment over the past 5 years, demonstrating their specific good therapeutic potential and superior tolerance. These natural therapies have been shown to mitigate myocardial cell damage caused by MI through mechanisms such as oxidative stress, inflammation, apoptosis, angiogenesis, myocardial fibrosis, autophagy, endoplasmic reticulum stress, mitophagy, and pyroptosis. This review offers the latest insights into the application of natural products and medicinal plants in MI treatment, elucidating their mechanisms of action and serving as an important reference for MI prevention.
冠心病是全球普遍存在的心血管疾病,心肌梗死(MI)是其最严重的表现之一。MI的发病率和死亡率不断上升,在年轻、高学历人群中呈上升趋势,对公众健康构成严重威胁。目前,溶栓、经皮冠状动脉介入治疗和冠状动脉旁路移植术是MI的主要临床治疗方法。尽管这些方法显著降低了患者死亡率,但并发症往往导致预后不良。由于化学合成药物研究的局限性,重点已转向基于天然物质开发草药。天然药物是一种更安全、更有效的MI管理和治疗新方法。它们可以通过针对各种途径和系统来控制多种致病变量。本文研究了MI的分子机制,并评估了过去5年天然产物和药用植物在MI治疗中的应用,证明了它们具有良好的治疗潜力和较高的耐受性。这些天然疗法已被证明可通过氧化应激、炎症、细胞凋亡、血管生成、心肌纤维化、自噬、内质网应激、线粒体自噬和细胞焦亡等机制减轻MI引起的心肌细胞损伤。本综述提供了天然产物和药用植物在MI治疗中应用的最新见解,阐明了它们的作用机制,为MI的预防提供了重要参考。